Contrasting Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Orthofix Medical (NASDAQ:OFIX)

Orthofix Medical (NASDAQ:OFIX) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Risk and Volatility

Orthofix Medical has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.25, indicating that its stock price is 125% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations for Orthofix Medical and Inspira Technologies OXY B.H.N., as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orthofix Medical	1	1	4	0	2.50
Inspira Technologies OXY B.H.N.	1	0	1	0	2.00

Orthofix Medical presently has a consensus target price of $21.50, indicating a potential upside of 35.05%. Inspira Technologies OXY B.H.N. has a consensus target price of $2.00, indicating a potential upside of 86.92%. Given Inspira Technologies OXY B.H.N.’s higher probable upside, analysts clearly believe Inspira Technologies OXY B.H.N. is more favorable than Orthofix Medical.

Earnings & Valuation

This table compares Orthofix Medical and Inspira Technologies OXY B.H.N.”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orthofix Medical	$818.06 million	0.77	-$126.00 million	($3.03)	-5.25
Inspira Technologies OXY B.H.N.	N/A	N/A	-$11.05 million	N/A	N/A

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Orthofix Medical.

Institutional and Insider Ownership

89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 1.3% of Orthofix Medical shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Orthofix Medical and Inspira Technologies OXY B.H.N.’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Orthofix Medical	-14.56%	-25.59%	-14.07%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

Summary

Inspira Technologies OXY B.H.N. beats Orthofix Medical on 7 of the 11 factors compared between the two stocks.

About Orthofix Medical

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

About Inspira Technologies OXY B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.